Synthesis and evaluation of a nanoglobular dendrimer 5-aminosalicylic acid conjugate with a hydrolyzable schiff base spacer for treating retinal degeneration

ACS Nano

Volumn 8, Issue 1, 2014, Pages 153-161

  Wu, Xueming ^a   Yu, Guanping ^a   Luo, Chengcai ^b   Maeda, Akiko ^c   Zhang, Ning ^c   Sun, Da ^a   Zhou, Zhuxian ^a   Puntel, Anthony ^a   Palczewski, Krzysztof ^c   Lu, Zheng Rong ^a  

^a Case Western Reserve University   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 aminosalicylic acid; controlled release; dendrimer; drug delivery; Schiff base

Indexed keywords

5-AMINOSALICYLIC ACIDS; CONTROLLED DELIVERY; CONTROLLED RELEASE; INTRAPERITONEAL INJECTIONS; LOW MOLECULAR WEIGHT; RETINAL DEGENERATIONS; SCHIFF-BASE; THERAPEUTIC AGENTS;

AMINO ACIDS; BIOCOMPATIBILITY; DRUG DELIVERY; FUNCTIONAL GROUPS; OPHTHALMOLOGY;

DENDRIMERS;

DENDRIMER; MESALAZINE; NANOMATERIAL; SCHIFF BASE;

ARTICLE; CHEMISTRY; HUMAN; HYDROLYSIS; RETINA DEGENERATION;

DENDRIMERS; HUMANS; HYDROLYSIS; MESALAMINE; NANOSTRUCTURES; RETINAL DEGENERATION; SCHIFF BASES;

EID: 84893493853     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn4054107     Document Type: Article

References (36)

1. Maeda, T.; Golczak, M.; Maeda, A. Retinal Photodamage Mediated by All- Trans -Retinal Photochem. Photobiol. 2012, 88, 1309-1319
2. Kiser, P. D.; Golczak, M.; Maeda, A.; Palczewski, K. Key Enzymes of the Retinoid (Visual) Cycle in Vertebrate Retina Biochim. Biophys. Acta 2012, 1821, 137-151
3. Palczewski, K. Retinoids for Treatment of Retinal Diseases Trends Pharmacol. Sci. 2010, 31, 284-295
4. Maeda, A.; Maeda, T.; Golczak, M.; Palczewski, K. Retinopathy in Mice Induced by Disrupted All- Trans -Retinal Clearance J. Biol. Chem. 2008, 283, 26684-26693
5. Maeda, A.; Golczak, M.; Chen, Y.; Okano, K.; Kohno, H.; Shiose, S.; Ishikawa, K.; Harte, W.; Palczewska, G.; Maeda, T. et al. Primary Amines Protect against Retinal Degeneration in Mouse Models of Retinopathies Nat. Chem. Biol. 2012, 8, 170-178
6. Klotz, U.; Maier, K. E. Pharmacology and Pharmacokinetics of 5-Aminosalicylic Acid Dig. Dis. Sci. 1987, 32, S46-S50
7. Gaudana, R.; Ananthula, H. K.; Parenky, A.; Mitra, A. K. Ocular Drug Delivery AAPS J. 2010, 12, 348-360
8. Geroski, D. H.; Edelhauser, H. F. Drug Delivery for Posterior Segment Eye Disease Invest. Ophthalmol. Vis. Sci. 2000, 41, 961-964
9. Del Amo, E. M.; Urtti, A. Current and Future Ophthalmic Drug Delivery Systems. A Shift to the Posterior Segment Drug Discovery Today 2008, 13, 135-143
10. Eljarrat-Binstock, E.; Pe'er, J.; Domb, A. J. New Techniques for Drug Delivery to the Posterior Eye Segment Pharm. Res. 2010, 27, 530-543
11. Chastain, J. E. General Considerations in Ocular Drug Delivery. In Ophthalmic Drug Delivery Systems; Mitra, A. K., Ed.; Marcel Dekker, Inc.: New York, 2003; pp 59-107.
12. Edelhauser, H. F.; Rowe-Rendleman, C. L.; Robinson, M. R.; Dawson, D. G.; Chader, G. J.; Grossniklaus, H. E.; Rittenhouse, K. D.; Wilson, C. G.; Weber, D. A.; Kuppermann, B. D. et al. Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications Invest. Ophthalmol. Vis. Sci. 2010, 51, 5403-5420
13. Babu, V. R.; Mallikarjun, V.; Nikhat, S. R.; Srikanth, G. Dendrimers: A New Carrier System for Drug Delivery Int. J. Pharm. Appl. Sci. 2010, 1, 1-10
14. Vandamme, T. F. Microemulsions as Ocular Drug Delivery Systems: Recent Developments and Future Challenges Prog. Retin. Eye Res. 2002, 21, 15-34
15. Kaur, I. P.; Garg, A.; Singla, A. K.; Aggarwal, D. Vesicular Systems in Ocular Drug Delivery: An Overview Int. J. Pharm. 2004, 269, 1-14
16. Barbu, E.; Verestiuc, L.; Iancu, M.; Jatariu, A.; Lungu, A.; Tsibouklis, J. Hybrid Polymeric Hydrogels for Ocular Drug Delivery: Nanoparticulate Systems from Copolymers of Acrylic Acid-Functionalized Chitosan and N -Isopropylacrylamide or 2-Hydroxyethyl Methacrylate Nanotechnology 2009, 20, 225108
17. Hacker, M. C.; Haesslein, A.; Ueda, H.; Foster, W. J.; Garcia, C. A.; Ammon, D. M.; Borazjani, R. N.; Kunzler, J. F.; Salamone, J. C.; Mikos, A. G. Biodegradable Fumarate-Based Drug-Delivery Systems for Ophthalmic Applications J. Biomed. Mater. Res. A 2009, 88, 976-989
18. Jiang, J.; Moore, J. S.; Edelhauser, H. F.; Prausnitz, M. R. Intrascleral Drug Delivery to the Eye Using Hollow Microneedles Pharm. Res. 2009, 26, 395-403
19. Kim, Y. C.; Park, J. H.; Prausnitz, M. R. Microneedles for Drug and Vaccine Delivery Adv. Drug Delivery Rev. 2012, 64, 1547-1568
20. Shirasaki, Y. Molecular Design for Enhancement of Ocular Penetration J. Pharm. Sci. 2008, 97, 2462-2496
21. Wadhwa, S.; Paliwal, R.; Paliwal, S. R.; Vyas, S. P. Nanocarriers in Ocular Drug Delivery: An Update Review Curr. Pharm. Des. 2009, 15, 2724-2750
22. Kuno, N.; Fujii, S. Recent Advances in Ocular Drug Delivery Systems Polymers 2011, 3, 193-221
23. Cheng, Y. Y.; Xu, Z. H.; Ma, M. L.; Xu, T. W. Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration J. Pharm. Sci. 2008, 97, 123-143
24. Medina, S. H.; El-Sayed, M. E. H. Dendrimers as Carriers for Delivery of Chemotherapeutic Agents Chem. Rev. 2009, 109, 3141-3157
25. Durairaj, C.; Kadam, R. S.; Chandler, J. W.; Hutcherson, S. L.; Kompella, U. B. Nanosized Dendritic Polyguanidilyated Translocators for Enhanced Solubility, Permeability, and Delivery of Gatifloxacin Invest. Ophthalmol. Vis. Sci. 2010, 51, 5804-5816
26. Vandamme, T. F.; Brobeck, L. Poly(amidoamine) Dendrimers as Ophthalmic Vehicles for Ocular Delivery of Pilocarpine Nitrate and Tropicamide J. Controlled Release 2005, 102, 23-38
27. Kambhampati, S. P.; Kannan, R. M. Dendrimer Nanoparticles for Ocular Drug Delivery J. Ocul. Pharmacol. Ther. 2013, 29, 151-165
28. Yang, H.; Tyagi, P.; Kadam, R. S.; Holden, C. A.; Kompella, U. B. Hybrid Dendrimer Hydrogel/PLGA Nanoparticle Platform Sustains Drug Delivery for One Week and Antiglaucoma Effects for Four Days Following One-Time Topical Administration ACS Nano 2012, 6, 7595-7606
29. Iezzi, R.; Guru, B. R.; Glybina, I. V.; Mishra, M. K.; Kennedy, A.; Kannan, R. M. Dendrimer-Based Targeted Intravitreal Therapy for Sustained Attenuation of Neuroinflammation in Retinal Degeneration Biomaterials 2012, 33, 979-988
30. Holden, C. A.; Tyagi, P.; Thakur, A.; Kadam, R.; Jadhav, G.; Kompella, U. B.; Yang, H. Polyamidoamine Dendrimer Hydrogel for Enhanced Delivery of Antiglaucoma Drugs Nanomedicine 2012, 8, 776-783
31. Kaneshiro, T. L.; Wang, X.; Lu, Z. R. Synthesis, Characterization, and Gene Delivery of Poly-L-lysine Octa(3-aminopropyl)silsesquioxane Dendrimers: Nanoglobular Drug Carriers with Precisely Defined Molecular Architectures Mol. Pharmaceutics 2007, 4, 759-768
32. Kaneshiro, T. L.; Jeong, E. K.; Morrell, G.; Parker, D. L.; Lu, Z. R. Synthesis and Evaluation of Globular Gd-DOTA-Monoamide Conjugates with Precisely Controlled Nanosizes for Magnetic Resonance Angiography Biomacromolecules 2008, 9, 2742-2748
33. Kratz, F.; Beyer, U.; Schutte, M. T. Drug-Polymer Conjugates Containing Acid-Cleavable Bonds Crit. Rev. Ther. Drug Carrier Syst. 1999, 16, 245-288
34. Saito, H.; Hoffman, A. S.; Ogawa, H. I. Delivery of Doxorubicin from Biodegradable PEG Hydrogels Having Schiff Base Linkages J. Bioact. Compat. Polym. 2007, 22, 589-601
35. Tan, M. Q.; Wu, X. M.; Jeong, E.-K.; Chen, Q. J.; Lu, Z. R. Peptide-Targeted Nanoglobular Gd-DOTA Monoamide Conjugates for Magnetic Resonance Cancer Molecular Imaging Biomacromolecules 2010, 11, 754-761
36. Maeda, A.; Maeda, T.; Golczak, M.; Imanishi, Y.; Leahy, P.; Kubota, R.; Palczewski, K. Effects of Potent Inhibitors of the Retinoid Cycle on Visual Function and Photoreceptor Protection from Light Damage in Mice Mol. Pharmacol. 2006, 70, 1220-1229